Rate, review and subscribe to Equity Mates Investing on Apple Podcasts 
  • Health is Wealth | How to Invest in this Game Changing Theme
    General

    Health is Wealth | How to Invest in this Game Changing Theme

    In this Episode they share insights into a game-changing theme that they believe is a critical allocation within your portfolio; Health and Biotech.

    23 February

  • Uncovered: Emyria (ASX: EMD)
    General

    Uncovered: Emyria (ASX: EMD)

    Nick Watchorn was a first responder at the Port Arthur Mass Shooting in Tasmania. He worked the scene of the crime for days after, and was left with images that will never leave him. Shortly after, Nick left the Tasmanian police force and was diagnosed with Post-Traumatic Stress Disorder (PTSD). For 20 years, Nick tried all kinds of treatment. From psychotherapy to pharmaceuticals, nothing worked.

    19th Feb, 2024

  • 2023 wrapped: the 6 biggest business stories
    General

    2023 wrapped: the 6 biggest business stories

    Today, we’re recapping the year that was. To do it, we’re bringing in the whole team at Equity Mates to share what they think are were the biggest business stories of the year.

    8 December

  • Uncovered: Imricor Medical Systems (ASX: IMR)
    General

    Uncovered: Imricor Medical Systems (ASX: IMR)

    When we first opened Imricor Medical’s website and turned to the About Us page, this is what we read: Imricor Medical Systems, Inc. (ASX:IMR) is a leading developer of innovative MRI-compatible medical devices which can be used to carry out MRI-guided cardiac catheter ablation procedures. It was at that moment we released this company is going to need a little explaining.

    29th Sep, 2023

  • The mystery of Long COVID is just beginning
    General

    The mystery of Long COVID is just beginning

    This article takes a look at the Long COVID clinic that has been set up at Yale Medical School and shares what doctors there are starting to find.

    7th Sep, 2023

  • What Happens When Private Equity Buys Your Doctor's Office?
    General

    What Happens When Private Equity Buys Your Doctor's Office?

    Private equity firms are investing heavily in healthcare, but a new study finds that this could lead to higher costs and worse care.

    16th Aug, 2023

  • Uncovered: EMVision Medical Devices (ASX:EMV)
    General

    Uncovered: EMVision Medical Devices (ASX:EMV)

    Here’s a stat that will blow you away: one in four people will have a stroke in their lifetime That number blew us away. The more we looked into it, the more we realised just how big a factor strokes will be in our lives and the lives of our friends and family. When it comes to strokes, time is brain. If you read those stats about strokes and got worried, you’re not alone. Today Alec talks to CEO Scott Kirkland about his vision for EMvision – where they offer healthcare systems a cheaper, more portable and more cost effective version. EMvision believes that one day they’ll be able to offer their portable brain scanner in a backpack. That means every ambulance can be equipped with one, transforming every ambulance into a mobile stroke unit.

    1st Aug, 2023

  • Eli Lily experimental obesity drug could beat rivals in total weight loss for patients
    General

    Eli Lily experimental obesity drug could beat rivals in total weight loss for patients

    Over the past six months it has been hard to miss, but we might still be underestimating the scale of what we’re living through.

    4th Jul, 2023

  • What if America sneezed and no-one cared?
    General

    What if America sneezed and no-one cared?

    As markets price in divergent trends, can the Federal Reserve cut rates without impacting the rest of the world?

    30th Jun, 2023

    Source: J.P Morgan Asset Management

  • Inside the secretive life-extension clinic
    General

    Inside the secretive life-extension clinic

    This article takes us down to Mexico where a new generation of treatments are being trialled.

    6th Jun, 2023

  • Uncovered: Hit-IQ (ASX: HIQ)
    General

    Uncovered: Hit-IQ (ASX: HIQ)

    We uncover Hit-IQ, an Australian healthcare company working to create a smart mouthguard that helps professional and amateur athletes alike monitor head knocks when playing sport

    30th Mar, 2023

  • Stock Story: Novo Nordisk - Key Contributor to Healthcare Innovation
    General

    Stock Story: Novo Nordisk - Key Contributor to Healthcare Innovation

    Munro Partners provide an overview of a stock set to benefit from healthcare innovation.

    1st Feb, 2023

    Source: Munro Partners

  • Can Mark Cuban solve America’s healthcare spending?

    Can Mark Cuban solve America’s healthcare spending?

    It is a surprising move for a television-star celebrity billionaire - that is, to start a Drug Company where Americans can access heavily discounted medicines. But it's what Mark Cuban has decided to do. Cuban - an early pioneer of internet streaming, the owner of the Dallas Mavericks NBA team, and Shark on the TV show Shark Tank - has entered the healthcare space with a company that carries his name: Mark Cuban’s Cost Plus Drugs. Today Alec and Sascha talk about how the company is solving the problem of America's spiralling healthcare costs... a problem that no company, politician or entrepreneur has been able to solve for decades.

    30 June

  • Fast growing healthcare companies | Jess Bell-Allen

    Fast growing healthcare companies | Jess Bell-Allen

    Are healthcare companies a good investment? Which stocks will be the game-changers in years to come? The healthcare industry is changing rapidly as we transition into a post-covid world and these companies are at the forefront of world-changing technology. It’s an exciting area full of investment opportunities, which is why we have asked Jess Bell-Allen from TDM Growth Partners on today to help us break down the industry and identify the greatest investing opportunities.

    14 June

  • How is AI changing the drug development process?

    How is AI changing the drug development process?

    We hear a lot about artificial intelligence, but as non-scientists, we're the first to admit we don't really understand how it works. But coming out of COVID, one of the most remarkable things about the past two years was the speed at which we developed drugs and vaccines. Many in the field are saying that the pandemic was the ultimate test of artificial intelligence and machine learning, and the technology passed with flying colours. Today Sascha and Alec look at how artificial intelligence is changing the drug development process and ask themselves - what could the future could look like?

    21 April

  • Making money while the world sleeps - Resmed | Summer Series

    Making money while the world sleeps - Resmed | Summer Series

    Bryce and Alec take a deep dive into Resmed, an Australian company dual-listed on the ASX (RMD) and NYSE (RMD). Resmed is a medical company, producing devices for the treatment of sleep apnea, neuromuscular disease, and other respiratory-related conditions. Resmed has a ~55% share of the global obstructive sleep apnea market, making it an incredibly important business.

    27 January

    Sponsored by Superhero

  • Cancer without Chemotherapy: A Totally Different World
    General

    Cancer without Chemotherapy: A Totally Different World

    A growing number of cancer patients, especially those with breast and lung cancers, are being spared chemotherapy and are able to explore other options. For decades, chemotherapy has been the best option when treating cancer.

    22nd Oct, 2021

Get the latest

Receive regular updates from our podcast teams, straight to your inbox.

The Equity Mates email keeps you informed and entertained with what's going on in business and markets
The perfect compliment to our Get Started Investing podcast series. Every week we’ll break down one key component of the world of finance to help you get started on your investing journey. This email is perfect for beginner investors or for those that want a refresher on some key investing terms and concepts.
The world of cryptocurrencies is a fascinating part of the investing universe these days. Questions abound about the future of the currencies themselves – Bitcoin, Ethereum etc. – and the use cases of the underlying blockchain technology. For those investing in crypto or interested in learning more about this corner of the market, we’re featuring some of the most interesting content we’ve come across in this weekly email.